GlassScriptPhysician profile
Carly Sarch
NPI 1932864253
$2,588.31
in general payments reported to CMS, 2019-2025
7 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $318 · 2024: $2,099 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321 · Travel and Lodging: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.62 |
| Travel and Lodging | $1,267.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,074.92 | 2024-2025 | Venaseal, Closurefast |
| Tactile Systems Technology INC | $195.54 | 2024 | Entre Plus, Flexitouch Plus |
| Mayne Pharma Commercial LLC | $151.35 | 2023 | |
| Daiichi Sankyo INC. | $77.03 | 2023 | Injectafer |
| Abbvie INC. | $52.53 | 2023 | |
| Agile Therapeutics, INC. | $20.00 | 2023 | Twirla |
| Integra Lifesciences Corporation | $16.94 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carly Sarch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.